DARE: Daré Bioscience, Inc. Amount of Cash per Share

Dare Bioscience, Inc. - graphic logo of issuer DARE

Dare Bioscience, Inc. (DARE) is optimizing expenses by outsourcing drug manufacturing and testing to external contractors. The average cash per share helps determine the optimal entry point, while the value of 0.59 reflects this status. Transparent management is effectively engaging with Organon, and modernized contract manufacturing capacities ensure the stable production of specialized women's health medications.

DARE - Dare Bioscience Inc. Cash per Share over the range 07/04/2022 - 11/20/2026

Analytical breakdowns for Dare Bioscience, Inc.

- market price and analyst price targets:
- cash availability and cash flow indicators:
Summary company analysis:DARE Dare Bioscience Inc.
Original product of Daré Bioscience

This metric is calculated by dividing the total net liquidity by the number of shares outstanding. The metric determines the financial safety cushion, protecting the company from bankruptcy while limiting aggressive growth rates. For Dare Bioscience, Inc. (DARE), this reserve is critical for organizing cross-border logistics of biocomponents and maintaining laboratory hubs. By analyzing the cash per share trend, an investor can promptly detect a trajectory reversal caused by rising costs.